Clark KEN - Search Results

1

The pan-PPAR agonist lanifibranor reduces development of lung fibrosis and attenuates cardiorespiratory manifestations in a transgenic mouse model of systemic sclerosis.

Derrett-Smith E, Clark KEN, Shiwen X, Abraham DJ, Hoyles RK, Lacombe O, Broqua P, Junien JL, Konstantinova I, Ong VH, Denton CP. Derrett-Smith E, et al. Among authors: clark ken. Arthritis Res Ther. 2021 Sep 6;23(1):234. doi: 10.1186/s13075-021-02592-x. Arthritis Res Ther. 2021. PMID: 34488870 Free PMC article.

2

Multiplex cytokine analysis of dermal interstitial blister fluid defines local disease mechanisms in systemic sclerosis.

Clark KE, Lopez H, Abdi BA, Guerra SG, Shiwen X, Khan K, Etomi O, Martin GR, Abraham DJ, Denton CP, Stratton RJ. Clark KE, et al. Arthritis Res Ther. 2015 Mar 23;17(1):73. doi: 10.1186/s13075-015-0575-8. Arthritis Res Ther. 2015. PMID: 25885360 Free PMC article.

3

Intravenous immunogobulin therapy for severe gastrointestinal involvement in systemic sclerosis.

Clark KE, Etomi O, Denton CP, Ong VH, Murray CD. Clark KE, et al. Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S168-70. Epub 2015 Aug 27. Clin Exp Rheumatol. 2015. PMID: 26315822

4

Multiplex serum protein analysis reveals potential mechanisms and markers of response to hyperimmune caprine serum in systemic sclerosis.

Quillinan N, Clark KE, Youl B, Vernes J, McIntosh D, Haq S, Denton CP. Quillinan N, et al. Arthritis Res Ther. 2017 Mar 7;19(1):45. doi: 10.1186/s13075-017-1252-x. Arthritis Res Ther. 2017. PMID: 28270187 Free PMC article. Clinical Trial.

5

Autoimmunity and immunodeficiency at the crossroad: autoimmune disorders as the presenting feature of selective IgM deficiency.

Campochiaro C, Atay S, Clark KEN, Ong V, Denton CP. Campochiaro C, et al. Among authors: clark ken. BMJ Case Rep. 2019 Jan 3;12(1):e223180. doi: 10.1136/bcr-2017-223180. BMJ Case Rep. 2019. PMID: 30610030 Free PMC article.

6

The patient knows best: a new self-reported outcome measure for systemic sclerosis.

Clark KEN, Denton CP. Clark KEN, et al. Br J Dermatol. 2020 Oct;183(4):610. doi: 10.1111/bjd.19033. Epub 2020 Apr 6. Br J Dermatol. 2020. PMID: 32253751 No abstract available.

7

Systemic sclerosis in pregnancy.

Clark KE, Etomi O, Ong VH. Clark KE, et al. Obstet Med. 2020 Sep;13(3):105-111. doi: 10.1177/1753495X19878042. Epub 2019 Oct 30. Obstet Med. 2020. PMID: 33093861 Free PMC article. Review.

8

Real-world experience of tocilizumab in systemic sclerosis: potential benefit on lung function for anti-topoisomerase-positive patients.

Suleman Y, Clark KEN, Cole AR, Ong VH, Denton CP. Suleman Y, et al. Among authors: clark ken. Rheumatology (Oxford). 2021 Aug 2;60(8):3945-3946. doi: 10.1093/rheumatology/keab273. Rheumatology (Oxford). 2021. PMID: 33734322 No abstract available.

9

Outcomes linked to eligibility for stem cell transplantation trials in diffuse cutaneous systemic sclerosis.

Spierings J, Nihtyanova SI, Derrett-Smith E, Clark KEN, van Laar JM, Ong V, Denton CP. Spierings J, et al. Among authors: clark ken. Rheumatology (Oxford). 2022 May 5;61(5):1948-1956. doi: 10.1093/rheumatology/keab604. Rheumatology (Oxford). 2022. PMID: 34314500 Free PMC article.

10

Combinations of scleroderma hallmark autoantibodies associate with distinct clinical phenotypes.

Clark KEN, Campochiaro C, Host LV, Sari A, Harvey J, Denton CP, Ong VH. Clark KEN, et al. Sci Rep. 2022 Jul 2;12(1):11212. doi: 10.1038/s41598-022-15062-4. Sci Rep. 2022. PMID: 35780179 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

44 results

Search Page